Ganguly R, Ogra PL, Regas S, et al: Rubella immunization of volunteers via the respiratory tract . Infect Immun 8:497-502, 1973;.
Rubella Vaccine: Advisory Committee on Immunization Practices , publication (HSM) 72-8154. US Dept of Health, Education, and Welfare, Center for Disease Control, 1972;, pp 23-25.
Plotkin SA, Farquhar JD, Katz M, et al: Attenuation of RA27/3 rubella virus in WI-38 human diploid cells . Am J Dis Child 118:178-185, 1969;.
Ferris RD: Laboratory tests for assessment of rubella vaccines . Postgrad Med J 48(
Plotkin SA, Bechtel DJ, Sedwick WD: A simple method for removal of rubella hemagglutination inhibitors from serum adaptable to fingertip blood . Am J Epidemiol 88:301-304, 1968;.
Meyer HM Jr, Parkman PD, Hobbins TE, et al: Clinical studies with experimental live rubella virus vaccine (strain HPV77): Evaluation of vaccine-induced immunity . Am J Dis Child 115:648-654, 1968;.
Meyer HM Jr, Parkman PD, Hopps HE: The control of rubella . Pediatrics 44:5-20, 1969;.
Detels R, Grayston JT, Kim KSW, et al: Prevention of clinical and subclinical rubella infection: Efficacy of three HPV-77 derivative vaccines . Am J Dis Child 118:295-300, 1969;.
Horstman DM, Pajot TG, Leibhaber H: Epidemiology of rubella: Subclinical infection and occurrence of reinfection . Am J Dis Child 118:133-136, 1969;.
Horstman DM, Liebhaber H, Le Bouvier GL, et al: Rubella reinfection of vaccinated and naturally immune persons exposed to an epidemic . N Engl J Med
283:771-778, 1970;.Link to Article
Ingalls TH, Plotkin SA, Philbrook FR, et al: Immunization of school children with rubella (RA27-3) vaccine . Lancet
1:99-101, 1970;.Link to Article
Buser F, Nicolas A: Vaccination with RA27/3 rubella vaccine . Am J Dis Child 122:53-56, 1971;.
Saidi S, Naficy K: Subcutaneous and intranasal administration of RA27/3 rubella vaccine: Alone and in conjunction with live attenuated measles vaccine . Am J Dis Child 118:209-212, 1969;.
Wallace RB, Isacson P: Comparative trial of HPV-77, DE-5 and RA27/3 live-attentuated rubella vaccines . Am J Dis Child 124:536-538, 1972;.
Plotkin SA, Farquhar JD, Ogra PL: Immunologic properties of RA27/3 rubella virus vaccine: A comparison with strains presently licensed in the United States . JAMA
225:585-590, 1973;.Link to Article
Tobin JOH: Rubella vaccination of postpartum women and of adolescents in the north west of England . Can J Public Health 62:64-67, 1971;.
Marshall WC: Rubella vaccination in adult and adolescent females . Can J Public Health 62:58-63, 1971;.
Dudgeon JA, Marshall WC, Peckham CS: Rubella vaccine trials in adults and children: Comparison of three attenuated vaccines . Am J Dis Child 118:237-242, 1969;.
Plotkin SA, Ingalls TH, Farquhar JD, et al: Intranasally administered rubella vaccine . Lancet
2:934-936, 1968;.Link to Article
Ogra PL, Kerr-Grant D, Umana G, et al: Antibody response in serum and nasopharynx after naturally acquired and vaccine induced infection with rubella virus . N Engl J Med
285:1333-1339, 1971;.Link to Article
Naficy K, Nategh R, Ahangary S, et al: Artificial challenge studies in rubella: Utilization of RA27/3 rubella vaccinees, rubella naturally acquired seropositives, and rubella susceptible children . Am J Dis Child 120:520-523, 1970;.
Liebhaber H, Ingalls TH, Le Bouvier GL, et al: Vaccination with RA27/3 rubella vaccine: Persistence of immunity and resistance to challenge after two years . Am J Dis Child 123:133-136, 1972;.